Diabetes Foot Care Clinical Pathway Project - Exciton Technologies Inc

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Exciton

"Exsalt® Wound Dressings will be applied by the physician/nursing staff.~The test product, exsalt® Wound Dressings (0.4 mg Ag/cm2) will be applied after wound cleansing or debridement if required.~Dressings will be changed weekly, either at the out-patient facility or at home with provided dressings. At regular intervals throughout the study, as per the existing Diabetes Foot Care Clinical Care Pathway, wound assessment including size determination, Exsalt Wound Assessment Form, any adverse events will be reported, with tracing and/or photography included where available.~Maximum treatment course will be 28 days (end of study) or until wound closure."

All Listed Sponsors
collaborator

Alberta Innovates Health Solutions

OTHER

collaborator

Exciton Technologies Inc.

INDUSTRY

lead

University of Alberta

OTHER